Verification of Medicinal Products in Europe Andreas M. WALTER EMVO General Manager Author - Date - Event
EMVO stakeholders have a common vision of medicines verification • Protect patients • Secure the legal supply chain • Be proactive as market partners • Set up a stakeholder-governed model that is • Functioning • Harmonised • Cost-effective • Inter-operable Author - Date - Event
Delegated Regulation will mandate rules for medicines verification Serialization by manufacturer + Verification at point of dispense Code (‘safety feature’) Product #: 09876543210982 Batch: A1C2E3G4I5 + Expiry: 140531 S/N: 12345AZRQF1234567890 Tamper evidence System set up and governed by stakeholders under supervision of authorities Author - Date - Event
Pan-European Structure National National System System National National System System European Parallel Hub Distributor Pharmaceutical Manufacturer National National System System Required by Delegated Regulation Wholesaler Pharmacy Author - Date - Event
EMVO members are allocated to a constituency Membership open to other stakeholder associations Author - Date - Event
Executive Summary Country Readiness 9 23 14 30 8 17 7 19 32 15 22 24 11 Early Adopter 2 2 6 0 27 Main Stream 1 1 13 8 10 31 Late Follower 28 26 4 No Information 16 3 Non EU Countries 29 25 12 2 1 5 Author - Date - Event
Questions? Author - Date - Event
Recommend
More recommend
